1. A non-hydrostatic non-Boussinesq algorithm for free-surface ocean modelling. (December 2018) Authors: Auclair, F.; Bordois, L.; Dossmann, Y.; Duhaut, T.; Paci, A.; Ulses, C.; Nguyen, C. Journal: Ocean modelling Issue: Volume 132(2018) Page Start: 12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Antineoplastic busulfan encapsulated in a metal organic framework nanocarrier: first in vivo results. Issue 4 (6th January 2016) Authors: Simon-Yarza, M. T.; Baati, T.; Paci, A.; Lesueur, L. L.; Seck, A.; Chiper, M.; Gref, R.; Serre, C.; Couvreur, P.; Horcajada, P. Journal: Journal of materials chemistry Issue: Volume 4:Issue 4(2016) Page Start: 585 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effects of azacitidine in 93 patients with IDH1/2 mutated acute myeloid leukemia/myelodysplastic syndromes: a French retrospective multicenter study. Issue 2 (28th January 2021) Authors: Willekens, C.; Rahme, R.; Duchmann, M.; Vidal, V.; Saada, V.; Broutin, S.; Delahousse, J.; Renneville, A.; Marceau, A.; Clappier, E.; Uzunov, M.; Rossignol, J.; Pascal, L.; Simon, L.; Micol, J. B.; Pasquier, F.; Raffoux, E.; Preudhomme, C.; Quivoron, C.; Itzykson, R. Journal: Leukemia & lymphoma Issue: Volume 62:Issue 2(2021) Page Start: 438 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effects of azacitidine in 93 patients with IDH1/2 mutated acute myeloid leukemia/myelodysplastic syndromes: a French retrospective multicenter study. Issue 2 (28th January 2021) Authors: Willekens, C.; Rahme, R.; Duchmann, M.; Vidal, V.; Saada, V.; Broutin, S.; Delahousse, J.; Renneville, A.; Marceau, A.; Clappier, E.; Uzunov, M.; Rossignol, J.; Pascal, L.; Simon, L.; Micol, J. B.; Pasquier, F.; Raffoux, E.; Preudhomme, C.; Quivoron, C.; Itzykson, R. Journal: Leukemia & lymphoma Issue: Volume 62:Issue 2(2021) Page Start: 438 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Phase I study of temsirolimus in combination with cetuximab in patients with advanced solid tumours. (August 2017) Authors: Hollebecque, A.; Bahleda, R.; Faivre, L.; Adam, J.; Poinsignon, V.; Paci, A.; Gomez-Roca, C.; Thery, J.C.; Le Deley, M.C.; Varga, A.; Gazzah, A.; Ileana, E.; Gharib, M.; Angevin, E.; Malekzadeh, K.; Massard, C.; Soria, J.C.; Spano, J.P. Journal: European journal of cancer Issue: Volume 81(2017) Page Start: 81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. SERUM 2‐HYDROXYGLUTARATE, A PREDICTIVE BIOMARKER OF THE PRESENCE OF IDH2 MUTATIONS IN AITL PATIENTS. (June 2017) Authors: Broutin, S.; Dupuy, A.; Koscielny, S.; Fataccioli, V.; Lemonnier, F.; de Leval, L.; Robe, C.; Pujals, A.; Safar, V.; Delarue, R.; Delfau‐Larue, M.H.; Ribrag, V.; Haioun, C.; Gaulard, P.; Paci, A. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 392 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The sustainability of the Italian water sector: An empirical analysis by DEA. (1st August 2019) Authors: Lombardi, G.V.; Stefani, G.; Paci, A.; Becagli, C.; Miliacca, M.; Gastaldi, M.; Giannetti, B.F.; Almeida, C.M.V.B. Journal: Journal of cleaner production Issue: Volume 227(2019) Page Start: 1035 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗